LifeStance Health Group, Inc. (NASDAQ:LFST) Shares Sold by Fmr LLC

FMR LLC trimmed its holdings in shares of LifeStance Health Group, Inc. (NASDAQ:LFST - Free Report) by 15.6% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 36,812,825 shares of the company's stock after selling 6,807,852 shares during the quarter. FMR LLC owned approximately 9.62% of LifeStance Health Group worth $257,690,000 as of its most recent SEC filing.

A number of other institutional investors have also recently added to or reduced their stakes in the stock. Vanguard Group Inc. lifted its stake in LifeStance Health Group by 1.3% during the first quarter. Vanguard Group Inc. now owns 7,668,966 shares of the company's stock worth $47,318,000 after purchasing an additional 95,197 shares in the last quarter. Price T Rowe Associates Inc. MD grew its position in LifeStance Health Group by 12.4% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 42,366 shares of the company's stock valued at $262,000 after acquiring an additional 4,681 shares in the last quarter. California State Teachers Retirement System lifted its position in shares of LifeStance Health Group by 13.0% during the first quarter. California State Teachers Retirement System now owns 95,758 shares of the company's stock worth $591,000 after purchasing an additional 11,022 shares in the last quarter. Virtu Financial LLC purchased a new position in shares of LifeStance Health Group in the first quarter valued at approximately $106,000. Finally, Bank of New York Mellon Corp grew its holdings in shares of LifeStance Health Group by 3.5% in the second quarter. Bank of New York Mellon Corp now owns 451,102 shares of the company's stock valued at $2,215,000 after purchasing an additional 15,309 shares in the last quarter. Institutional investors and hedge funds own 85.50% of the company's stock.

LifeStance Health Group Stock Down 0.5 %

NASDAQ LFST traded down $0.04 during trading hours on Monday, reaching $7.48. 480,067 shares of the company traded hands, compared to its average volume of 1,525,706. The company has a current ratio of 1.32, a quick ratio of 1.32 and a debt-to-equity ratio of 0.19. LifeStance Health Group, Inc. has a 12 month low of $4.64 and a 12 month high of $9.20. The company has a 50 day moving average of $7.09 and a two-hundred day moving average of $6.27. The stock has a market capitalization of $2.86 billion, a PE ratio of -28.81 and a beta of 1.24.

LifeStance Health Group (NASDAQ:LFST - Get Free Report) last issued its earnings results on Thursday, November 7th. The company reported ($0.02) EPS for the quarter, beating analysts' consensus estimates of ($0.07) by $0.05. LifeStance Health Group had a negative return on equity of 6.66% and a negative net margin of 7.90%. The company had revenue of $312.70 million during the quarter, compared to the consensus estimate of $302.25 million. During the same period in the previous year, the firm posted ($0.17) earnings per share. LifeStance Health Group's quarterly revenue was up 18.9% compared to the same quarter last year. As a group, equities analysts expect that LifeStance Health Group, Inc. will post -0.22 earnings per share for the current year.

Analysts Set New Price Targets

A number of research analysts recently commented on the stock. Barclays increased their target price on shares of LifeStance Health Group from $6.00 to $7.00 and gave the company an "underweight" rating in a research report on Monday, November 11th. UBS Group decreased their price objective on LifeStance Health Group from $9.00 to $7.50 and set a "neutral" rating for the company in a report on Thursday, August 15th. One equities research analyst has rated the stock with a sell rating, two have issued a hold rating and two have given a buy rating to the stock. According to MarketBeat.com, the stock currently has an average rating of "Hold" and an average price target of $8.50.

About LifeStance Health Group

LifeStance Health Group, Inc, through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.